|
|
Invivyd Inc (NASDAQ: IVVD) |
|
*Market share is calculated based on total revenue.
News about Invivyd Inc Contracts |
July 1, 2024
Invivyd Joins Prestigious Russell 2000 and Russell 3000 Indexes, Solidifying Its Position in the Biopharmaceutical IndustryWALTHAM, Mass., July 1, 2024 - Invivyd, Inc. (Nasdaq: IVVD), a leading biopharmaceutical company dedicated to combatting serious viral infectious diseases, is excited to announce its inclusion in the prestigious Russell 2000 Index and the broad-market Russell 3000 Index. This strategic move, effective today with the opening of U.S. equity markets, is a significant milestone for Invivyd and reinforces its growing influence in the biopharmaceutical industry.The Russell indexes, widely regarded as critical indicators of stock market performance, are compiled by FTSE Russell, a subsidiary of...
|
April 15, 2024
Invivyd Receives HCPCS Reimbursement Codes and FDA Authorization for PEMGARDA: A Breakthrough Prophylaxis Against COVID-19WALTHAM, Mass., March 22, 2024 - Invivyd, Inc. (Nasdaq: IVVD), a renowned biopharmaceutical company committed to safeguarding the vulnerable population against severe viral infectious diseases, announced today a significant milestone for PEMGARDA (pemivibart). Previously known as VYD222, this half-life extended monoclonal antibody (mAb) has been granted emergency use authorization (EUA) by the U.S. Food and Drug Administration (FDA) for the pre-exposure prophylaxis (prevention) of COVID-19 in adults and adolescents (12 years of age and older) who suffer from moderate-to-severe immune comp...
|
Publicly Traded Peers of Invivyd Inc
Moderna Inc
Share Performance
+13.37%
30 Days
|
Moderna Inc
Profile
Moderna Inc's business model revolves around the development and commercialization of mRNA-based therapeutics and vaccines. They focus on using messenger RNA (mRNA) technology to create drugs that can help prevent and treat various diseases.
More about Moderna Inc 's Market Share
|
Pfizer Inc
Share Performance
-13.42%
This Year
|
Pfizer Inc
Profile
Pfizer Inc operates as a global pharmaceutical company that focuses on researching, developing, manufacturing, and marketing innovative medicines. Its business model emphasizes significant investment in research and development to build a diverse portfolio of therapies across various therapeutic areas, while leveraging strategic alliances and collaborations to enhance commercialization and drive growth.
More about Pfizer Inc's Market Share
|
Novavax inc
Share Performance
-6.91%
This Quarter
|
Novavax inc
Profile
Novavax Inc is a biotechnology company focused on the discovery, development, and commercialization of novel vaccines. They aim to leverage their proprietary recombinant nanoparticle vaccine technology platform to address a wide range of infectious diseases. By collaborating with partners and conducting clinical trials, Novavax works towards bringing innovative vaccines to the global market.
More about Novavax inc 's Market Share
|
Regeneron Pharmaceuticals Inc
Share Performance
-11.18%
This Quarter
|
Regeneron Pharmaceuticals Inc
Profile
Regeneron Pharmaceuticals Inc operates a business model centered on the discovery and commercialization of cutting-edge biopharmaceuticals, particularly in the fields of ophthalmology, oncology, immunology, and rare diseases. They leverage their strong research and development capabilities, including their proprietary technologies, to create innovative therapies that address unmet medical needs. Additionally, Regeneron forms strategic collaborations and partnerships to enhance their development pipeline and expand market access for their products.
More about Regeneron Pharmaceuticals Inc 's Market Share
|
Alector Inc
Share Performance
-74.58%
One Year
|
Alector Inc
Profile
Alector Inc's business model focuses on developing novel therapeutics for neurodegenerative diseases using its proprietary platform and partnering with pharmaceutical companies for clinical trials and commercialization.
More about Alector Inc 's Market Share
|
Dyadic International Inc
Share Performance
0.00%
30 Days
|
Dyadic International Inc
Profile
Dyadic International Inc's business model revolves around developing and licensing proprietary microbial strains and technologies for use in the biopharmaceutical, biofuels, and industrial enzyme industries.
More about Dyadic International Inc's Market Share
|
Allogene Therapeutics Inc
Share Performance
+21.75%
Over The Past 5 Days
|
Allogene Therapeutics Inc
Profile
Allogene Therapeutics Inc has a business model that focuses on developing and commercializing innovative allogeneic CAR T cell therapies for the treatment of cancer.
More about Allogene Therapeutics Inc 's Market Share
|
Ambrx Biopharma Inc
Share Performance
+201.72%
One Year
|
Ambrx Biopharma Inc
Profile
Ambrx Biopharma Inc's business model can be described as a biopharmaceutical company that focuses on developing protein therapeutics through the use of its proprietary technology called ReCODE?.
More about Ambrx Biopharma Inc 's Market Share
|
Apogee Therapeutics Inc
Share Performance
+15.49%
This Quarter
|
Apogee Therapeutics Inc
Profile
Apogee Therapeutics Inc is a biopharmaceutical company that focuses on developing innovative therapies for various medical conditions. Their business model revolves around conducting extensive research to identify potential drug candidates, and then advancing them through preclinical and clinical trials to secure regulatory approvals. By licensing or partnering with larger pharmaceutical companies, Apogee Therapeutics aims to bring these drugs to market and improve patient outcomes.
More about Apogee Therapeutics Inc 's Market Share
|
Armata Pharmaceuticals Inc
Share Performance
+68.47%
30 Days
|
Armata Pharmaceuticals Inc
Profile
Armata Pharmaceuticals Inc operates on a research and development business model focused on discovering and developing bacteriophage-based therapies to combat antibiotic-resistant infections. They utilize their proprietary phage technology platform to create novel pharmaceutical products targeting various bacterial diseases.
More about Armata Pharmaceuticals Inc 's Market Share
|
Axcella Health Inc
Share Performance
-94.20%
This Quarter
|
Axcella Health Inc
Profile
Axcella Health Inc is a biotechnology company that operates with a novel business model. They focus on discovering and developing Endogenous Metabolic Modulators (EMMs) as potential therapeutics for various diseases. Their approach revolves around leveraging the body's natural metabolic pathways to address unmet medical needs, with an emphasis on designing EMM compositions that can impact multiple targets simultaneously.
More about Axcella Health Inc 's Market Share
|
Biontech Se
Share Performance
+10.46%
Over The Past 5 Days
|
Biontech Se
Profile
Biontech SE's business model focuses on the development and commercialization of novel mRNA-based immunotherapies for various diseases, including cancer.
More about Biontech Se's Market Share
|
Candel Therapeutics Inc
Share Performance
-34.26%
This Year
|
Candel Therapeutics Inc
Profile
Candel Therapeutics Inc's business model is centered around developing and commercializing advanced biotherapeutics for the treatment of cancer. They aim to leverage their proprietary oncolytic viral immunotherapy technology to deliver targeted therapies that stimulate the patient's immune system to attack and eliminate tumors. Through partnerships and collaborations, they seek to expand their reach and accelerate the development and delivery of innovative treatments.
More about Candel Therapeutics Inc 's Market Share
|
Calidi Biotherapeutics Inc
Share Performance
-62.20%
This Year
|
Calidi Biotherapeutics Inc
Profile
Calidi Biotherapeutics Inc's business model revolves around developing and commercializing innovative cell-based immunotherapies for the treatment of cancer.
More about Calidi Biotherapeutics Inc 's Market Share
|
Compass Therapeutics Inc
Share Performance
-33.75%
This Quarter
|
Compass Therapeutics Inc
Profile
Compass Therapeutics Inc operates as a biotechnology company focused on discovering and developing novel antibody therapeutics for the treatment of cancer and autoimmune diseases. Their business model revolves around leveraging their proprietary Targeted Immunomodulation platform to identify and advance multiple antibody candidates through preclinical and clinical development stages.
More about Compass Therapeutics Inc 's Market Share
|
Eiger Biopharmaceuticals Inc
Share Performance
+4.55%
Over The Past 5 Days
|
Eiger Biopharmaceuticals Inc
Profile
Eiger Biopharmaceuticals Inc is a biotechnology company focused on developing and commercializing innovative therapies for serious rare and ultra-rare diseases.
More about Eiger Biopharmaceuticals Inc 's Market Share
|
Tradeup Acquisition Corp
Share Performance
-12.50%
This Year
|
Tradeup Acquisition Corp
Profile
Estrella Immunopharma Inc is a biotechnology company that focuses on developing innovative immunotherapies. They have a business model centered around researching, developing, and commercializing novel treatments for various diseases. Their approach includes leveraging the power of the immune system to target and eradicate diseases, with a particular emphasis on cancer.
More about Tradeup Acquisition Corp's Market Share
|
Evaxion Biotech A
Share Performance
+6.71%
Over The Past 5 Days
|
Evaxion Biotech A
Profile
Evaxion Biotech is a company that operates on a business model centered around the development and commercialization of innovative immunotherapies, leveraging artificial intelligence and machine learning technologies to identify and target specific antigens for the treatment of cancer and infectious diseases. These therapies are intended to improve patient outcomes and bring about advancements in the field of precision medicine.
More about Evaxion Biotech A's Market Share
|
Finch Therapeutics Group Inc
Share Performance
-6.21%
This Quarter
|
Finch Therapeutics Group Inc
Profile
Finch Therapeutics Group Inc's business model revolves around developing microbiome-based therapies for various diseases and conditions.
More about Finch Therapeutics Group Inc 's Market Share
|
Gritstone Bio Inc
Share Performance
-98.52%
This Year
|
Gritstone Bio Inc
Profile
Gritstone Bio Inc is a biotechnology company that focuses on developing personalized cancer immunotherapies. Their business model revolves around utilizing their proprietary genomics platform to identify patient-specific tumor targets and developing therapies that stimulate the immune system to recognize and attack cancer cells.
More about Gritstone Bio Inc 's Market Share
|
Hillevax Inc
Share Performance
0.00%
30 Days
|
Hillevax Inc
Profile
Hillevax Inc's business model is centered around a specific product or service that they offer to customers.
More about Hillevax Inc 's Market Share
|
Immunitybio inc
Share Performance
-57.38%
One Year
|
Immunitybio inc
Profile
Immunitybio Inc operates on a business model that focuses on developing and commercializing innovative immunotherapies and vaccines to address various diseases and medical conditions. They aim to use their broad scientific expertise, technology platforms, and strategic partnerships to advance their products and improve patient outcomes in healthcare.
More about Immunitybio inc 's Market Share
|
Icosavax Inc
Share Performance
-3.59%
This Year
|
Icosavax Inc
Profile
Icosavax Inc's business model focuses on developing and commercializing vaccines to address infectious diseases.
More about Icosavax Inc 's Market Share
|
In8bio Inc
Share Performance
-87.13%
One Year
|
In8bio Inc
Profile
In8bio Inc operates as a clinical-stage biotechnology company that focuses on developing transformative therapies for the treatment of cancer and other diseases. The company follows a research and development model centered on leveraging their proprietary platform to identify and optimize novel genetic circuits for targeted cell-based therapies.
More about In8bio Inc 's Market Share
|
Intensity Therapeutics Inc
Share Performance
-13.78%
Over The Past 5 Days
|
Intensity Therapeutics Inc
Profile
Intensity Therapeutics Inc's business model involves developing and commercializing novel intratumoral cancer immunotherapy products. They aim to target and destroy tumors within the body through the direct application of their proprietary drug, leading to an enhanced immune response and potential treatment for various cancers.
More about Intensity Therapeutics Inc 's Market Share
|
Lexeo Therapeutics Inc
Share Performance
-76.47%
One Year
|
Lexeo Therapeutics Inc
Profile
Lexeo Therapeutics Inc is a biotechnology company focused on developing advanced gene therapies for the treatment of genetic disorders. Their business model revolves around leveraging cutting-edge technology and scientific expertise to develop innovative gene therapies that address significant unmet medical needs. They aim to bring these therapies to market through strategic partnerships and collaborations with pharmaceutical companies and academic institutions.
More about Lexeo Therapeutics Inc 's Market Share
|
Molecular Partners Ag
Share Performance
+10.06%
One Year
|
Molecular Partners Ag
Profile
Molecular Partners Ag is a biotechnology company that operates on an innovative business model focused on the development of therapeutic drugs. The company utilizes its proprietary DARPin technology platform to create a pipeline of potential treatments for various diseases. Molecular Partners Ag primarily collaborates with strategic partners, including pharmaceutical companies, to advance its drug candidates through preclinical and clinical development stages.
More about Molecular Partners Ag's Market Share
|
Nkgen Biotech Inc
Share Performance
-84.09%
One Year
|
Nkgen Biotech Inc
Profile
Nkgen Biotech Inc is a biotechnology company that focuses on developing and commercializing innovative cell therapies for the treatment of various diseases. Their business model involves conducting extensive research to identify and isolate specific cells capable of addressing medical conditions, followed by developing manufacturing processes to produce these cells in large quantities. They aim to partner with healthcare providers and pharmaceutical companies to ensure the effective distribution and delivery of their therapies to patients in need.
More about Nkgen Biotech Inc 's Market Share
|
Vaxcyte Inc
Share Performance
+9.94%
Over The Past 5 Days
|
Vaxcyte Inc
Profile
Vaxcyte Inc's business model revolves around developing and commercializing vaccines to prevent diseases with a focus on advancing innovative approaches to address unmet medical needs. They aim to create value by leveraging their scientific expertise, conducting clinical studies, obtaining regulatory approvals, and efficiently manufacturing and distributing vaccines worldwide.
More about Vaxcyte Inc 's Market Share
|
Peak Bio Inc
Share Performance
0.00%
This Year
|
Peak Bio Inc
Profile
Peak Bio Inc is a biotechnology company specializing in the development and commercialization of innovative medical products. Their business model focuses on conducting extensive research and development to create cutting-edge biopharmaceuticals. These products are then marketed and distributed to healthcare providers and patients, aiming to improve patient outcomes and contribute to advancements in the healthcare industry.
More about Peak Bio Inc 's Market Share
|
Prime Medicine Inc
Share Performance
-85.37%
One Year
|
Prime Medicine Inc
Profile
Prime Medicine Inc is a biotechnology company specializing in gene editing technologies and therapeutics. Their business model revolves around harnessing advanced CRISPR-based gene editing techniques to develop treatments for genetic diseases. By using innovative science and strategic partnerships, the company aims to bring transformative therapies to patients in need.
More about Prime Medicine Inc 's Market Share
|
Mosaic Immunoengineering Inc
Share Performance
0.00%
One Year
|
Mosaic Immunoengineering Inc
Profile
Mosaic Immunoengineering Inc's business model revolves around leveraging cutting-edge technologies and expertise in immunoengineering to develop innovative solutions and therapies for immune-related diseases.
More about Mosaic Immunoengineering Inc 's Market Share
|
Recursion Pharmaceuticals Inc
Share Performance
-53.04%
One Year
|
Recursion Pharmaceuticals Inc
Profile
Recursion Pharmaceuticals Inc is a biotech company that utilizes its artificial intelligence (AI) platform to identify and develop potential drug candidates. They employ a unique approach by combining AI technology with experimental biology and automation to accelerate drug discovery. Recursion applies its platform to identify new treatments for rare diseases and have established partnerships with various organizations in the pharmaceutical industry.
More about Recursion Pharmaceuticals Inc 's Market Share
|
Sana Biotechnology Inc
Share Performance
+21.52%
This Year
|
Sana Biotechnology Inc
Profile
Sana Biotechnology Inc operates as a biotechnology company that focuses on developing and commercializing cellular therapies for various diseases. Their business model involves leveraging innovative technologies and collaborations with clinical and industry partners to develop advanced medical treatments.
More about Sana Biotechnology Inc 's Market Share
|
Sqz Biotechnologies Company
Share Performance
0.00%
Over The Past 5 Days
|
Sqz Biotechnologies Company
Profile
Sqz Biotechnologies Company's business model revolves around developing and commercializing innovative cell engineering platforms for multiple applications across the healthcare industry.
More about Sqz Biotechnologies Company's Market Share
|
Sorrento Therapeutics Inc
Share Performance
0.00%
This Year
|
Sorrento Therapeutics Inc
Profile
Sorrento Therapeutics Inc is a biopharmaceutical company that focuses on developing and commercializing innovative therapies for various diseases, including cancer, autoimmune disorders, and pain management.
More about Sorrento Therapeutics Inc 's Market Share
|
Sutro Biopharma Inc
Share Performance
-53.84%
This Quarter
|
Sutro Biopharma Inc
Profile
Sutro Biopharma Inc has a business model focused on developing and commercializing innovative antibody-based therapeutics.
More about Sutro Biopharma Inc 's Market Share
|
Tourmaline Bio Inc
Share Performance
-21.51%
This Year
|
Tourmaline Bio Inc
Profile
Tourmaline Bio Inc's business model revolves around the development and commercialization of innovative healthcare solutions.
More about Tourmaline Bio Inc 's Market Share
|
Turnstone Biologics Corp
Share Performance
-35.94%
This Year
|
Turnstone Biologics Corp
Profile
Turnstone Biologics Corp is a biotechnology company that focuses on developing innovative cancer treatments. Their business model includes leveraging their proprietary vaccinia virus-based platform to engineer oncolytic viral immunotherapies. These therapies are designed to selectively target and destroy cancer cells while also activating the patient's immune system to generate a lasting anti-tumor response.
More about Turnstone Biologics Corp 's Market Share
|
Valneva Se
Share Performance
-21.83%
One Year
|
Valneva Se
Profile
Valneva is a biotech company that specializes in the development and commercialization of vaccines. Their business model revolves around research, development, manufacturing, and distribution of vaccines for various infectious diseases. Valneva aims to partner with pharmaceutical companies, governments, and international organizations to bring safe and effective vaccines to the market, addressing global health challenges.
More about Valneva Se's Market Share
|
Vir Biotechnology Inc
Share Performance
-53.67%
One Year
|
Vir Biotechnology Inc
Profile
Vir Biotechnology Inc is a clinical-stage immunology company that focuses on developing and commercializing innovative treatments for infectious diseases. Their business model revolves around the discovery and development of antibody therapies and other immunological approaches to combat a wide range of viral pathogens. They collaborate with leading research institutions and pharmaceutical companies to accelerate the development and commercialization of their products.
More about Vir Biotechnology Inc 's Market Share
|
Vaxart Inc
Share Performance
+27.00%
Over The Past 5 Days
|
Vaxart Inc
Profile
Vaxart Inc's business model involves the development of oral vaccines through their proprietary tablet vaccine delivery platform.
More about Vaxart Inc 's Market Share
|
Bluebird Bio Inc
Share Performance
0.00%
Over The Past 5 Days
|
Bluebird Bio Inc
Profile
Bluebird Bio Inc's business model focuses on developing gene therapies for severe genetic diseases and cancer. They collaborate with academic and industry partners to leverage their gene editing and cell-based technologies for discovering potential treatments and advancing these therapies through clinical trials.
More about Bluebird Bio Inc 's Market Share
|
Coeptis Therapeutics Holdings Inc
Share Performance
+43.32%
One Year
|
Coeptis Therapeutics Holdings Inc
Profile
Coeptis Therapeutics Holdings Inc. is a pharmaceutical company that focuses on the development and commercialization of innovative therapies. Their business model involves researching, formulating, and manufacturing drugs to address unmet medical needs in various therapeutic areas. They aim to bring these treatments to market to improve patient outcomes and generate revenue through sales and licensing agreements.
More about Coeptis Therapeutics Holdings Inc 's Market Share
|
Gamida Cell Ltd
Share Performance
-94.81%
One Year
|
Gamida Cell Ltd
Profile
Gamida Cell Ltd's business model is focused on developing and bringing innovative cell therapies to market for the treatment of various diseases, with a particular emphasis on hematological malignancies and serious blood disorders.
More about Gamida Cell Ltd 's Market Share
|
Mymetics Corporation
Share Performance
0.00%
This Quarter
|
Mymetics Corporation
Profile
Mymetics Corporation is a biotechnology company that focuses on the development of innovative vaccines and therapeutic products to address global health challenges. Their business model involves research, development, and commercialization of these products through collaborations and partnerships with pharmaceutical companies and government organizations.
More about Mymetics Corporation's Market Share
|
Sab Biotherapeutics Inc
Share Performance
-12.65%
This Quarter
|
Sab Biotherapeutics Inc
Profile
Sab Biotherapeutics Inc's business model focuses on developing and producing innovative antibody therapeutics using advanced genetic engineering techniques.
More about Sab Biotherapeutics Inc 's Market Share
|
Instil Bio Inc
Share Performance
+23.70%
Over The Past 5 Days
|
Instil Bio Inc
Profile
Instil Bio Inc operates with a business model focusing on developing and commercializing innovative cell therapy products for the treatment of cancer. They aim to leverage advanced technologies and strategic partnerships to advance their pipeline and bring novel therapies to market.
More about Instil Bio Inc 's Market Share
|
Cardiol Therapeutics inc
Share Performance
0.00%
30 Days
|
Cardiol Therapeutics inc
Profile
Cardiol Therapeutics Inc. operates on a business model focused on the research and development of pharmaceutical-grade cannabidiol (CBD) and targeted therapies for cardiovascular diseases. The company aims to leverage its expertise to develop innovative and effective treatments to address unmet medical needs in the field of heart-related conditions.
More about Cardiol Therapeutics inc 's Market Share
|
Innate Pharma Sa
Share Performance
-9.40%
This Quarter
|
Innate Pharma Sa
Profile
Innate Pharma SA's business model revolves around the development and commercialization of innovative cancer immunotherapies.
More about Innate Pharma Sa's Market Share
|
Opthea Limited
Share Performance
-7.34%
This Year
|
Opthea Limited
Profile
Opthea Limited operates as a clinical stage biotechnology company, primarily focused on the development of novel therapies for the treatment of eye diseases. The company pursues its business model by leveraging its expertise in the discovery and development of innovative therapeutics, while collaborating with strategic partners and conducting clinical trials to bring its products to market.
More about Opthea Limited's Market Share
|
Cullinan Therapeutics Inc
Share Performance
+10.80%
Over The Past 5 Days
|
Cullinan Therapeutics Inc
Profile
Cullinan Oncology Inc's business model focuses on developing innovative cancer treatments by identifying and acquiring promising drug candidates through collaborations and partnerships with academic institutions and biotechnology companies. They prioritize the advancement of these therapies towards clinical trials and commercialization, aiming to address unmet medical needs in the field of oncology.
More about Cullinan Therapeutics Inc 's Market Share
|
Sources: Invivyd Inc and all companies mentioned above in this report
|
